U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474350) titled 'Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida' on March 11.
Brief Summary: Labour is a physiological process that enables the natural delivery of fetus, placenta and membranes after the age of viability.
This study compared the efficacy of valethamate bromide and hyoscine butyl bromide in reducing labour duration among primigravid women at Alex Ekwueme Federal University Teaching Hospital, Abakaliki
Study Start Date: Sept. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Labour Duration
Primigravida
Intervention:
DRUG: Valethamate Bromide
Two ml (16mg) of valethamate bromide ...